ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO195

The Case of the Hairy Kidneys

Session Information

Category: Onconephrology

  • 1700 Onconephrology

Authors

  • Khan, Nazish, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
  • Derebail, Vimal K., The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
  • Bonner, Ryan, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
  • Moreno, Vanessa, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Introduction

Erdheim-Chester disease (ECD) is a multi-organ infiltrative disease due to to non-Langerhans histiocytosis, causing mostly bone and skin lesions. Kidney involvement occurs in 30% of patients.

Case Description

A 54-year-old male with hypertension experienced flank pain and was diagnosed with kidney stones 4 years prior. He had sclerotic bone lesions on imaging and biopsies demonstrated non-specific myelofibrosis. More recently, he had worsening flank pain and renal insufficiency. By computed tomography, extensive bilateral perinephric edema and fat stranding was seen, identified as "hairy kidney sign”, a finding pathognomonic for ECD. Kidney biopsy was performed to establish diagnosis and perform genetic sequencing and demonstrated macrophage-predominant histiocytic infiltrate. Tissue was BRAF negative by immunohistochemistry, but BRAF positive by molecular analysis. The patient was diagnosed with ECD based on his clinical, imaging, and biopsy findings and began MAPK/extracellular signal regulated kinase (MEK) inhibitor therapy.

Discussion

Fewer than 1,000 cases of ECD are reported. Somatic mutations of BRAF or other MAPK signaling pathway components result in myeloid progenitor cell proliferation. Kidney involvement presents as reduced glomerular filtration rate, perinephric stranding, hydronephrosis, renovascular hypertension, or flank pain with infiltration and enlarged kidneys. Tissue biopsy (often skin or kidney) establishes diagnosis and identifies mutations for targeted therapy.

CT scan with extensive bilateral perinephric stranding